retatrutide vs cagrisema vs Survodutide: Three Next-Gen Weight Loss Drugs Compared Retatrutide vs Cagrilintide: The Ultimate

Lancet Diabetes Endocrinol 7(10):776785 Vilsbll T, Christensen M, Junker AE, Knop FK, Gluud LL (2012) Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

If you have any questions or concerns, please talk to a medical professional

Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic beta cells

[DOI] [PubMed] [Google Scholar] 17.Bailey TS

If a consumer can buy Wegovy or Zepbound for $350 directly from the manufacturer, employers are right to ask: Why should our health plan pay more than an individual paying cash? This transparency sets the stage for employers to push for: Mid-cycle GLP-1 repricing or rebate true-ups Most-favored-net clauses guaranteeing parity with manufacturer DTC pricing Dose-specific caps to prevent runaway spend as members titrate upward Even without an immediate financial impact, this public price signal changes the tone of employer-PBM negotiations heading into 2026